Rationale, design and protocol of a cross-sectional study on pregnancy-related cardiovascular diseases in Tanzania (PRECARDT): burden, characterisation and prognostic significance at delivery.
Abel MakubiPilly ChilloReuben MutagaywaBelinda BalandyaPeter KisengeVincent TarimoEva MujuniEvarist B MsakiJosephine MgayaAlbert KihunrwaMohamed JanabiGideon KwesigaboJulie MakaniLindsay KendallJuliet AddoBruno MmbandoKaren SliwaPublished in: BMJ open (2021)
The study is being conducted in accordance with the Helsinki declaration on studies involving human subjects. Ethical approvals have been obtained from Muhimbili University (reference number DA.282/298/01.C/) and Bugando Medical Centre (reference number CREC/330/2019) Ethics Committees. Informed consent is sought from all potential participants before any interview or investigations are performed. Study findings will be disseminated to the scientific community through different methods. Results will also be communicated to policymakers and to the public, as appropriate.
Keyphrases
- healthcare
- cardiovascular disease
- mental health
- endothelial cells
- randomized controlled trial
- clinical trial
- public health
- risk factors
- emergency department
- physical activity
- type diabetes
- machine learning
- preterm birth
- risk assessment
- cardiovascular risk factors
- induced pluripotent stem cells
- decision making
- cardiovascular events
- case control
- pluripotent stem cells
- electronic health record
- adverse drug